Category: Pharmaceuticals
Japan Pharmaceuticals
-
Asia-Pacific Omega-3 Supplements Market, By Source (Fish Oil, Krill Oil, Algae Oil, Others), By Form (Tablets, Capsules, Soft Gels, Others), By Functionality (Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, Others), By End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, ... Read More
-
Japan Weight Loss Management Market Overview, 2029
... on domestic fixed-income investments, catering to the needs of individual savers and institutional investors like life insurance companies. However, the liberalization of financial markets in the 1980s and 1990s paved the way for diversification, including ... Read More
-
Japan Parenteral Nutrition Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the parenteral nutrition market are highlighted in the study. ... Read More
-
Japan Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the Japan market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the diabetes devices and drugs ... Read More
-
Japan Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... billion by 2029, growing at a CAGR of 0.88% during the forecast period (2024-2029). The COVID-19 pandemic significantly impacted the pharmaceutical market in Japan. The increased COVID-19 infection cases in the country increased the demand ... Read More
-
Japan Insulin Drugs and Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 9.57 billion by 2029, growing at a CAGR of 2.40% during the forecast period (2024-2029). The number of Japanese victims during the COVID-19 pandemic was lower than in ... Read More
-
Global Japanese Encephalitis Vaccines Market 2024-2028
... encephalitis vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Japan Herbal Tea Market, By Raw Material (Black Tea, Green Tea, Yellow Tea), By Type (Cinnamon, Dandelion, Chamomile, Ginger, Turmeric, Blends), By Product Type (Syrups, Premixes, Powdered Ready to Drink, Liquid Ready to Drink), By Packaging Type (Loose Tea, Paper Pouches, Tea Bags, Carton Packs, Can Packaging), By Function (Cognitive Health, Gut & Digestive Health, Multifunctional), By Distributional Channel (Store Based, Non-Store Based), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Packaging Type (Loose Tea, Paper Pouches, Tea Bags, Carton Packs, Can Packaging), By Function (Cognitive Health, Gut & Digestive Health, Multifunctional), By Distributional Channel (Store Based, Non-Store Based), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 ... Read More
-
Japan AI in Medical Diagnostics Market Assessment, By Component Type [Software, Hardware, Services], By Diagnosis Type [In-Vitro Diagnostics, Diagnostic Imaging, Others], By Application [Oncology, Neurology, Cardiology, Radiology, Pulmonology, Obstetrics/Gynecology, Others], By Technology [Natural Language Processing, Machine Learning, Context-Aware Computing, Computer Vision], By End-user [Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Machine Learning, Context-Aware Computing, Computer Vision], By End-user [Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan AI in medical diagnostics market size was valued at USD 82.3 million in ... Read More
-
Japan Ventilator Market Assessment, By Mobility [Intensive Care Ventilators, Portable/Transportable Ventilators], By Type [Adult Ventilators, Pediatric Ventilators, Neonatal/Infant Ventilators], By Interface [Invasive Ventilators, Non-Invasive Ventilators], By Mode [Combined Mode Ventilators, Volume Mode Ventilators, Pressure Mode Ventilators, Others], By End-user [Hospitals, Clinics, Ambulatory Care Centers, Home Care Settings, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Ventilators, Others], By End-user [Hospitals, Clinics, Ambulatory Care Centers, Home Care Settings, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan Ventilator Market size was valued at USD 353 million in FY2023, which is expected to ... Read More
-
Japan Active Pharmaceutical Ingredient Market Assessment, By Synthesis [Biotech, Synthetic], By Potency [Traditional API, HPAPI], By Manufacturer [Captive APIs, Merchant APIs], By Type [Generic APIs, Innovative APIs], By Drug [Prescription Drugs, Over-the-counter Drugs], By Usage [Clinical, Research], By Application [Cardiovascular diseases, Oncology, Neurology, Orthopedic, Diabetes, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... [Clinical, Research], By Application [Cardiovascular diseases, Oncology, Neurology, Orthopedic, Diabetes, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan Active pharmaceutical ingredient market size was valued at USD 20.11 billion in FY2023, ... Read More
-
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2024-2032
... vaccines market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.6% during 2024-2032. The market is ... Read More
-
Asia Pacific Next Generation Antibody Market, By Therapeutic Area (Oncology, Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADC's), Bispecific Antibodies, FC Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, Biosimilar Antibody Products); By Country (China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... antibody research and development programs, advancements in biotechnology, and expanding healthcare infrastructure. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Next Generation Antibody Market size ... Read More
-
2024 Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Te
... TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), ... Read More
-
Japan Eyelid Surgery Blepharoplasty Market Forecast 2024-2032
... by factors such as growing awareness of cosmetic efficacy and surgical device advancements. The base year considered for the market study is 2023, and the forecast years are from 2024 to 2032. MARKET INSIGHTS Blepharoplasty ... Read More
-
Cannabis in Japan
... Control Law was passed in December 2023, which will allow for the domestic use of medicines made from cannabis plants. It also allows for the cultivation of cannabis plants for the purpose of collecting raw ... Read More
-
Japan: Eye Care Products Market - Analysis, Size, Trends, Consumption, and Forecast
... of COVID-19 on it, and a forecast for the market development in the medium term. The report provides a strategic analysis of the eye care products market in Japan and describes the main market participants, ... Read More
-
Japan Thyroid Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Argentina market. Also, factors that are driving and restraining the industrial emission control systems market are ... Read More
-
Medcore: Japan Dental Prosthetics Market Size, Share & Trends Analysis - 2024-2030 - Includes: Crowns, Bridges, Dentures & Dental CAD/CAM Prosthetics, and 3 more
... recorded a value of nearly $5.7 billion. Projections indicate a growth trajectory throughout the forecast period, with a Compound Annual Growth Rate (CAGR) of 3.8%, reaching a figure of $7.4 billion. The comprehensive report suite ... Read More
-
Japan Ophthalmic Procedures Count and Forecast to 2030
... volumes within segments - Ophthalmic Viscoelastic Devices (OVD) Procedures, Intraocular Lens (IOL) Procedures and Glaucoma Procedures The Japan Ophthalmic Procedures report provides key information and data on - Procedure volume data for Japan Ophthalmic Procedures ... Read More
-
Japan Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the artemisinin combination therapy market are highlighted ... Read More
-
Japan Ankylosing Spondylitis Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the ankylosing spondylitis drugs market are highlighted ... Read More
-
Japan Eczema Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the eczema therapeutics market are highlighted in the study. ... Read More
-
Japan In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan In Vitro Diagnostics Market size ... Read More
-
Asia Pacific Multiple Sclerosis Drugs Market, By Disease Type (Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing-Remitting Multiple Sclerosis (RES)); By Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies); By Drug Type (Branded, Generic); By End User (Hospital & Clinics, Diagnostic Laboratories); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029
... End User (Pharmaceutical & Biopharmaceutical Companies, Labs & Research Institutes, Healthcare Providers, Healthcare Payers); By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis); By Region (North America, Europe, Asia ... Read More
Research Assistance
